Li Chen

Li Chen

Auto-generated profile, based on publicly available information

Li Chen

School of Pharmacy, Zunyi Medical University, Zunyi 563000, People's Republic of China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
LCLiu Chang-Shun
Liu Chang-Shun
LCLi Chen
Li Chen
YHYan-Nan Hu
Yan-Nan Hu
JDJin-Lian Dai
Jin-Lian Dai
BMBiao Ma
Biao Ma
XTXiaomei Tan
Xiaomei Tan
Purpose: Ferulic acid (FA) is a natural compound which is used to treat insomnia. However, its use is limited because of its poor oral bioavailability caused by extremely rapid elimination. The current study aimed to develop a self-microemulsifying drug delivery system (SMEDDS) to improve the oral delivery of FA and to enhance its hypnotic efficacy. Methods: FA-SMEDDS was prepared, and its morphology and storage stability were characterized. The formulation was also subjected to pharmacokinetic and tissue distribution studies in rats. The hypnotic efficacy of FA-SMEDDS was evaluated in p-chlorophenylalanine-induced insomnia mice. Results: FA-loaded SMEDDS exhibited a small droplet size (15.24 nm) and good stability. Oral administration of FA-SMEDDS yielded relative bioavailability of 185.96%. In the kidney, SMEDDS decreased the distribution percentage of FA from 76.1% to 59.4% and significantly reduced its metabolic conversion, indicating a reduction in renal elimination. Interestingly, FA-SMEDDS showed a higher distribution in the brain and enhanced serotonin levels in the brain, which extended the sleep time by 2-fold in insomnia mice. Conclusion: This is the first study to show that FA-loaded SMEDDS decreased renal elimination, enhanced oral bioavailability, increased brain distribution, and improved hypnotic efficacy. Thus, we have demonstrated that SMEDDS is a promising carrier which can be employed to improve the oral delivery of FA and facilitate product development for the therapy of insomnia.

1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LCLi Chen
Li Chen
LCLiu Chang-Shun
Liu Chang-Shun
QCQing-Zhen Chen
Qing-Zhen Chen
SWSen Wang
Sen Wang
YXYong-Ai Xiong
Yong-Ai Xiong
JLJia-Jia Lv
Jia-Jia Lv